NCT01596413 2024-07-26
Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years
Kyowa Kirin Co., Ltd.
Phase 1 Withdrawn
Clinical Trials
3 trialsNCT01596426 2024-07-26
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years
Kyowa Kirin Co., Ltd.
Phase 1 Withdrawn
NCT00891761 2015-04-17
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
GlaxoSmithKline
Phase 3 Withdrawn